Literature DB >> 24343800

The development of peripheral T-cell lymphoma after successful treatment for diffuse large B-cell lymphoma in a patient with suspected adult onset immunodeficiency: more questions than answers?

Mari Frances Kilner1, Serena Merante, Alexandr Svec.   

Abstract

We present the case of a 60-year-old woman who developed peripheral T-cell lymphoma following successful treatment for high-grade B-cell non-Hodgkin's lymphoma. We consider the possible aetiology of this unusual occurrence. We hypothesise that this case represents one of the undiagnosed adult-onset immunodeficiency, in which the pathogenesis of the patient's T-cell lymphoma may have been in part iatrogenic, namely related to previous immunotherapy with rituximab. We feel this case highlights the importance of rebiopsy in patients with recurrent lymphadenopathy and a history of haematological malignancy and hence acts as an important aide memoir in the investigation of such cases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24343800      PMCID: PMC3888542          DOI: 10.1136/bcr-2013-200079

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma.

Authors:  I N Micallef; A Kirk; A Norton; J M Foran; A Z Rohatiner; T A Lister
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

2.  Peripheral T-cell lymphoma after anti-CD20 antibody therapy.

Authors:  S Tetreault; S L Abler; B Robbins; A Saven
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

3.  Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis.

Authors:  Erika Irie; Yuko Shirota; Chihiro Suzuki; Yumi Tajima; Kenichi Ishizawa; Junichi Kameoka; Hideo Harigae; Tomonori Ishii
Journal:  Int J Hematol       Date:  2010-03-10       Impact factor: 2.490

Review 4.  EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.

Authors:  C Cameron Yin; L Jeffrey Medeiros; Lynne V Abruzzo; Dan Jones; Anwar I Farhood; Vilmos A Thomazy
Journal:  Am J Clin Pathol       Date:  2005-02       Impact factor: 2.493

5.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

6.  Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome.

Authors:  C A Sander; L J Medeiros; L M Weiss; T Yano; M C Sneller; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1992-12       Impact factor: 6.394

7.  Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis.

Authors:  Antonio Martinez; Stefania Pittaluga; Neus Villamor; Dolors Colomer; Maria Rozman; Mark Raffeld; Emili Montserrat; Elias Campo; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

8.  Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.

Authors:  Takashi Oyama; Kazuhito Yamamoto; Naoko Asano; Aya Oshiro; Ritsuro Suzuki; Yoshitoyo Kagami; Yasuo Morishima; Kengo Takeuchi; Toshiyuki Izumo; Shigeo Mori; Koichi Ohshima; Junji Suzumiya; Naoya Nakamura; Masafumi Abe; Koichi Ichimura; Yumiko Sato; Tadashi Yoshino; Tomoki Naoe; Yoshie Shimoyama; Yoshikazu Kamiya; Tomohiro Kinoshita; Shigeo Nakamura
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

9.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

Authors:  Helen Chapel; Mary Lucas; Martin Lee; Janne Bjorkander; David Webster; Bodo Grimbacher; Claire Fieschi; Vojtech Thon; Mohammad R Abedi; Lennart Hammarstrom
Journal:  Blood       Date:  2008-03-04       Impact factor: 22.113

10.  Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia.

Authors:  J C Kluin-Nelemans; M G Kester; J J Melenhorst; J E Landegent; L van de Corput; R Willemze; J H Falkenburg
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

View more
  1 in total

1.  Sequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma.

Authors:  Jing-Wen Wang; Jia-Yan Chen; Chen Lu; Xi Tang
Journal:  Cancer Biol Ther       Date:  2017-02-25       Impact factor: 4.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.